Get started
Author

Mónica Marino

Observed names: M. Marino, Monica Marino, Mónica P. Marino
ORCID: 0000-0003-4356-1070
Observed ORCID: 0000-0003-4356-1070
OpenAlex ID: A5062071817
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide
2018 · Salvatore Piano, Virendra Singh, et al. · Gastroenterology · 528
PDF
Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure
2020 · Florence Wong, Salvatore Piano, et al. · Journal of Hepatology · 176
Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: A multicenter prospective study
2014 · Rubén Terg, Paola Casciato, et al. · Journal of Hepatology · 123
PDF
Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity
2015 · Melisa Dirchwolf, Ariel Podhorzer, et al. · Cytokine · 118
Effectiveness of ketoacidosis prevention campaigns at diagnosis of type 1 diabetes in children: A systematic review and meta-analysis
2021 · Valentino Cherubini, Monica Marino, et al. · Diabetes Research and Clinical Practice · 58
Effectiveness of a closed‐loop control system and a virtual educational camp for children and adolescents with type 1 diabetes: A prospective, multicentre, real‐life study
2021 · Valentino Cherubini, Ivana Rabbone, et al. · Diabetes Obesity and Metabolism · 30
PDF
Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy
2021 · Alberto E Muñoz, Florencia D Pollarsky, et al. · World Journal of Gastroenterology · 27
Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study
2025 · Kavish R Patidar, Ann T Ma, et al. · The Lancet. Gastroenterology & hepatology · 26
Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury
2020 · Alberto E. Muñoz, Florencia Pollarsky, et al. · Digestive Diseases and Sciences · 25
Effectiveness and safety of original and generic sofosbuvir for the treatment of chronic hepatitis C: A real world study
2018 · Sebastián Marciano, Leila Haddad, et al. · Journal of Medical Virology · 22
Determinants of clinical response to empirical antibiotic treatment in patients with cirrhosis and bacterial and fungal infections—Results from the ICA “Global Study” (EABCIR-Global Study)
2023 · Rakhi Maiwall, Salvatore Piano, et al. · Hepatology · 21
PDF
Weekend-Based Parent-Group Intervention to Reduce Stress in Parents of Children and Adolescents with Type 1 Diabetes: A Pilot Study
2019 · Lucia Ferrito, Barbara Predieri, et al. · Journal of Diabetes Research · 19
PDF
Epidemiology, predictors and outcomes of multi drug resistant (MDR) bacterial infections in patients with cirrhosis across the world. Final results of the “Global study”
2018 · S. Piano, V. Singh, et al. · Digestive and Liver Disease · 17
Epidemiology, predictors and outcomes of multi drug resistant bacterial infections in patients with cirrhosis across the world. Final results of the “Global study”
2018 · S. Piano, V. Singh, et al. · Journal of Hepatology · 7
Development and external validation of a model to predict multidrug‐resistant bacterial infections in patients with cirrhosis
2024 · Sebastián Marciano, Salvatore Piano, et al. · Liver International · 6
PDF
Real-World Use of Terlipressin in Cirrhosis and Acute Kidney Injury: Frequent Use Beyond Hepatorenal Syndrome
2025 · Ann T. Ma, Adrià Juanola, et al. · Clinical Gastroenterology and Hepatology · 5
PDF
Baseline Severity and Inflammation Would Influence the Effect of Simvastatin on Clinical Outcomes in Cirrhosis Patients
2023 · Alberto E. Muñoz, Florencia Pollarsky, et al. · Digestive Diseases and Sciences · 4
Hepatitis autoinmune: conceptos actuales
2023 · Mónica P. Marino · Acta gastroenteorológica latinoamericana/Acta gastroenterológica latinoamericana · 3
PDF
Addition of simvastatin to standard treatment is safe, effective and improves quality of life in patients with decompensated cirrhosis
2018 · A. Muñoz, F. Pollarsky, et al. · Journal of Hepatology · 3
Development and external validation of a model to predict multi-drug resistant bacterial infections in patients with cirrhosis
2023 · Sebastián Marciano, Salvatore Piano, et al. · Journal of Hepatology · 2
Real-world practice patterns on the use of terlipressin in patients with cirrhosis and acute kidney injury - results from the ICA-GLOBAL AKI study
2025 · S. Incicco, A.T. MA, et al. · Digestive and Liver Disease · 1
Guía de diagnóstico y tratamiento del hígado graso no alcohólico. Asociación Argentina para el estudio de las enfermedades del hígado, año 2019.
2020 · E Fassio, Melisa Dirchwolf, et al. · CONICET Digital (CONICET) · 1
PDF
Regional variations in the development of acute-on-chronic liver failure (ACLF) in patients with cirrhosis and bacterial infections
2018 · F. Wong, V. Singh, et al. · Journal of Hepatology · 1
Adherence to EASL antibiotic treatment recommendations improves the outcomes of patients with cirrhosis and bacterial infections. Results from the ICA “Global Study”
2018 · S. Piano, V. Singh, et al. · Digestive and Liver Disease · 1
Impact of non-selective beta-blockers on acute kidney injury outcomes in patients with decompensated cirrhosis
2026 · Simone Incicco, Kavish R. Patidar, et al. · Journal of Hepatology
Works count: 35
Citation count: 1,224
H-index: 13
I10-index: 13
Year
Topic
Type